Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Wool follicles are complex, involving interactions between different cell types and structures.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Loose Anagen Hair Syndrome is a hereditary condition causing hair loss in children due to abnormal hair follicles.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.